Fideuram - Intesa Sanpaolo Private Banking S.p.a. »

Apellis Pharmaceuticals shares owned by Fideuram - Intesa Sanpaolo Private Banking S.p.a.

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Fideuram - Intesa Sanpaolo Private Banking S.p.a. from 13F filings

Historical chart of Fideuram - Intesa Sanpaolo Private Banking S.p.a. investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Fideuram - Intesa Sanpaolo Private Banking S.p.a. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Fideuram - Intesa Sanpaolo Private Banking S.p.a.

Quarter filed Position value Share count Share price at filing
2025-12-31 $100 4 25.00

More positions owned by Fideuram - Intesa Sanpaolo Private Banking S.p.a.

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Applied Materials (AMAT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Gilead Sciences (GILD)
Wal-Mart Stores (WMT)
Autodesk (ADSK)
Broadcom (AVGO)
Abbvie (ABBV)
Eli Lilly & Co. (LLY)
salesforce (CRM)
JPMorgan Chase & Co. (JPM)
Verizon Communications (VZ)

View all positions for Fideuram - Intesa Sanpaolo Private Banking S.p.a.

Top funds holding Apellis Pharmaceuticals

venBio Select Advisor
Vanguard Group
Wellington Management Company
Deep Track Capital
BlackRock
AQR Capital Management
UBS Group
State Street Corporation
EcoR1 Capital
Suvretta Capital Management
Polar Capital Holdings
Siren
OrbiMed Advisors
Geode Capital Management
Deutsche Bank Aktiengesellschaft

View all funds holding Apellis Pharmaceuticals